IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CANTI, GIANFRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.453
NA - Nord America 3.868
AS - Asia 2.958
SA - Sud America 341
AF - Africa 35
OC - Oceania 11
Totale 12.666
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.817
GB - Regno Unito 2.158
CN - Cina 930
SE - Svezia 854
SG - Singapore 787
IT - Italia 539
DE - Germania 462
RU - Federazione Russa 428
HK - Hong Kong 304
TR - Turchia 286
BR - Brasile 277
NL - Olanda 222
KR - Corea 215
UA - Ucraina 179
IE - Irlanda 174
FR - Francia 146
IN - India 146
FI - Finlandia 127
EU - Europa 101
VN - Vietnam 97
JP - Giappone 43
ID - Indonesia 37
GR - Grecia 34
BE - Belgio 30
PL - Polonia 30
CA - Canada 22
BD - Bangladesh 19
CO - Colombia 19
IQ - Iraq 19
DK - Danimarca 15
ES - Italia 13
MX - Messico 13
AR - Argentina 12
UZ - Uzbekistan 11
CI - Costa d'Avorio 10
VE - Venezuela 9
EG - Egitto 8
PK - Pakistan 8
SA - Arabia Saudita 8
NO - Norvegia 7
CH - Svizzera 6
CL - Cile 6
EC - Ecuador 6
NZ - Nuova Zelanda 6
PH - Filippine 6
ZA - Sudafrica 6
AU - Australia 5
CZ - Repubblica Ceca 5
MA - Marocco 5
TW - Taiwan 5
AT - Austria 4
MY - Malesia 4
PY - Paraguay 4
RO - Romania 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
AZ - Azerbaigian 3
BG - Bulgaria 3
GE - Georgia 3
IL - Israele 3
KH - Cambogia 3
KZ - Kazakistan 3
PS - Palestinian Territory 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
JO - Giordania 2
LV - Lettonia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BM - Bermuda 1
BY - Bielorussia 1
EE - Estonia 1
HU - Ungheria 1
IM - Isola di Man 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
ML - Mali 1
NI - Nicaragua 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TM - Turkmenistan 1
TN - Tunisia 1
Totale 12.766
Salva come PNG Salva come JPEG
Città #
Southend 1.884
Singapore 489
Seattle 345
Dallas 302
Hong Kong 296
Chandler 295
Milan 231
Princeton 209
Santa Clara 196
Wilmington 192
Beijing 186
Dublin 174
Ashburn 162
Council Bluffs 162
Hanover 137
Redmond 136
Frankfurt am Main 118
Los Angeles 118
Ann Arbor 115
Mountain View 105
Sakarya 98
Kent 90
Des Moines 80
Buffalo 78
Nanjing 78
Fairfield 75
The Dalles 66
Woodbridge 66
Bengaluru 64
Jacksonville 62
Columbus 60
Boardman 59
Moscow 50
Dearborn 46
Eitensheim 46
Jinan 46
Dong Ket 44
Guangzhou 43
Houston 39
Tokyo 38
Shenyang 37
Athens 34
Hefei 33
Shanghai 31
Changsha 29
Munich 29
Serra 29
Brussels 28
New York 27
Hebei 26
Zhengzhou 25
Seoul 24
Cangzhou 22
Warsaw 22
Jakarta 21
Nanchang 21
Phoenix 21
Helsinki 20
Andover 19
São Paulo 19
Bitonto 18
Cambridge 17
Falls Church 17
Tianjin 16
Bogotá 15
Somerville 15
Ningbo 14
Redwood City 13
San Diego 13
San Martino Siccomario 13
Fremont 11
Jiaxing 11
Tashkent 11
Abidjan 10
Sunnyvale 10
London 9
Toronto 9
Wuhan 9
Yubileyny 9
Auburn Hills 8
Chennai 8
Fuzhou 8
Hangzhou 8
Kunming 8
Medford 8
Naples 8
Rio de Janeiro 8
Taizhou 8
Baghdad 7
Berlin 7
Chengdu 7
Roxbury 7
Turin 7
Brasília 6
Chicago 6
Curitiba 6
Istanbul 6
Lanzhou 6
Turku 6
Washington 6
Totale 7.986
Salva come PNG Salva come JPEG
Nome #
Melatonin Analogue Antiproliferative and Cytotoxic Effects on Human Prostate Cancer Cells 357
Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells 339
B cell lymphoma (Bcl)-2 protein is the major determinant in bcl-2 adenine-uridine-rich element turnover overcoming HuR activity 293
Computational modeling of the metabolic states regulated by the kinase Akt 232
Bcl-2 protein is required for the adenine/uridine-rich element (ARE)-dependent degradation of its own messenger 219
Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt 217
Inhibition of tumor cell proliferation by linear polyunsaturated aldehydes 201
Increased bcl2 expression by antisense oligoribonucleotides targeting the adenine-uridine-rich element motif 199
Antitumor activity of photodynamic therapy, adoptive immunotherapy, and chemotherapy in experimental tumor 197
Terapia fotodinamica e nuovi fotosensibilizzanti 192
Fotoimmunologia. In Fotodermatologia 186
Combination of photodynamic therapy + immunotherapy + chemotherapy in murine leukiemia 179
Systems biology of the metabolic network regulated by the Akt pathway 179
Assimilation of LDL by experimental tumours in mice 179
Stabilization of cellular mRNAs and up-regulation of proteins by oligoribonucleotides homologous to the Bcl2 adenine-uridine rich element motif 177
Low doses of cisplatin or gemcitabine plus photofrin/photodynamic therapy : disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non-small cell lung cancer cells (H1299) 170
[The pharmacologic activity of 1(2-(p-chloro-alpha-phenylbenzyloxy)ethyl)piperidine (cloperastine)] 165
Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light 163
Preferential chemosensitization of PTEN-mutated prostate cells by silencing the Akt kinase 158
A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines 157
Cell survival under nutrient stress is dependent on metabolic conditions regulated by Akt and not by autophagic vacuoles 154
Alterazioni antigeniche indotte da dimetil-triazeno-carbossamide (DTIC) nella leucemia L1210. Attivita' citotossica in vitro di splenociti immuni. 150
Action spectrum of photoactivated phthalocyanine AIS2Pc in tumor bearing mice 149
Safety and efficacy of living BCG or BCG cell walls (CW) in the treatment of guinea pig hepatoma 149
Immunoprophylaxis of syngeneic methycholanthrene-induced murine sarcomas with Bacillus Calmette-Guérin and tumor cells 146
2-[125i]iodomelatonin binding in normal and neoplastic tissues 145
Toxicity of fenclor 42 in mice: effects on immunocompetent cells 144
Rapamycin increases the cellular concentration of the BCL-2 protein and exerts an anti-apoptotic effect 143
Photodynamic effects of porphyrin and chlorin photosensitizers in human colon adenocarcinoma cells 141
In vitro hematoporphyrin (Hpd) inhibitory effects on some immunological assays 141
Immunopharmacology studies on photosensitizers used in photodynamic therapy (PDT) 141
Effect of the tiapamil analog RO11-2933 on cellular sensitivity to antitumor drugs in sensitive and multidrug resistant human ovarian cancer cells 139
Efficacy of photodynamic therapy against doxorubicin-resistant murine tumors 138
Adoptive immunotherapy in BALB-c times DBA-2 Cr F1 mice bearing an immunogenic subline of L1210 leukemia 138
Adoptive immunity in mice challenged with L1210/DTIC clones 136
DTIC xenogenized lines obtained from an L1210 clone: clonal analysis of cytotoxic T lymphocyte reactivity 135
Hematoporphyrin derivative rescue from toxicity caused by chemotherapy or radiation in a murine leukemia model (L1210) 134
Cell proliferation and cell cycle alterations in oesophageal p53-mutated cancer cells treated with cisplatin in combination with photodynamic therapy 132
Use of time-gated fluorescence imaging for diagnosis in biomedicine 132
Decay time images of HpD fluorescence for tumor detection in mice 131
Antitumor efficacy of the combination of photodynamic therapy and chemotherapy in murine tumors 131
Haematoporphyrin-treated murine lymphocytes: in vitro inhibition of DNA synthesis and light-mediated inactivation of cells responsible for GVHR 130
Immunological cross-reactivity between H-2Dk product and DTIC-treated H-2d lymphoma 129
Comparative study of the therapeutic effect of photoactivated hematoporphyrin derivative and aluminum disulfonated phthalocyanines on tumor bearing mice 128
[Possible applications of living BCG and the BCG cell wall in immunotherapy] 128
Oligonucleotide degradation contributes to resistance to antisense compounds 128
Laser oncology in Italy: experimental research and clinical applications at the National Cancer Institute, Milan 128
Chemotherapy and immunotherapy of L1210 leukemic mice with antigenic tumor sublines 127
L1210/DTIC antigenic subline: studies at the clone level 126
Serotherapy of L1210 murine leukaemia--reasons for ineffectiveness of in vivo treatment by L.1 monoclonal antibody 125
Fluorescence molecular tomography of an animal model using structured light rotating view acquisition 125
Fluorescence molecular tomography on animal model by means of multiple views structured light illumination 124
Hematoporphyrin derivative photoradiation therapy in murine solid tumors 123
Monoclonal antibody to L1210 leukemia: characterization and therapeutic activity 122
Effect of photodynamic therapy with photoactivated aluminum disulfonated phthalocyanine on antitumor immune response 119
In vivo assimilation of low density lipoproteins by a fibrosarcoma tumour line in mice 117
B16 melanoma response in vivo to photochemotherapy with mitoxantrone and red light 116
Tumor detection in mice by measurement of fluorescence decay time matrices 116
Induction of new antigenic properties on DTIC-treated L1210 clones 113
Preliminary evaluation of two fluorescence imaging methods for the detection and the delineation of basal cell carcinomas of the skin 113
Photodynamic therapy in vitro and in vivo with hematoporphyrin derivative and laser light 111
Immunotherapy of bilateral lymph node metastases in guinea pigs by intralesional or paralesional injection of Mycobacterium bovis (BCG) 111
Humoral and cellular immunoresponse of mice treated with pyrazole-carboxamide-4-amino (PCA). 106
Study on the absorption properties of sulphonated aluminum phthalocyanine in vivo and ex vivo in murine tumor models 104
Eradication by immunization with mycobacterial vaccines and tumor cells of microscopic metastases remaining after surgery 104
Absorption spectrum of hematoporphyrin derivative in vivo in a murine tumor model 104
Tumour visualization in a murine model by time-delayed fluorescence of sulphonated aluminium phthalocyanine 104
Study of porphyrin fluorescence in tissue samples of tumour-bearing mice 102
Fluorescence lifetime imaging of experimental tumors in hematoporphyrin derivative-sensitized mice 101
Oligonucleotides induce apoptosis restricted to the t(14;18) DHL-4 cell line 101
Absorption spectra of photosensitizers detected in vivo in tumor bearing mice 100
Photoradiation therapy with Hpd and laser light 100
Time-gated fluorescence imaging of different organs in tumor-bearing mice after porphyrin administration 99
Investigation of the system copper(II) carbonic anhydrase and HCO3-/CO2 99
Time-gated fluorescence spectroscopy of porphyrin derivatives and aluminium phthalocyanine incorporated in vivo in a murine ascitic tumour model 99
Photodynamic therapy and immune response in tumor-bearing mice 95
Regression of established oral tumors after intralesional injection of living BCG or BCG cell walls 94
delta-Aminolevulinic acid induced fluorescence in tumour-bearing mice 94
PLASMA RETINOL LEVELS AND SIDE-EFFECTS FOLLOWING HIGH-DOSE RETINYL ACETATE IN BREAST-CANCER PATIENTS 93
Time-gated fluorescence imaging for the diagnosis of tumors in a murine model 93
Two-step photoactivation of porphyrins with nanosecond red pulses 93
Fluorescence imaging during photodynamic therapy of experimental tumors in mice sensitized with disulfonated aluminum phthalocyanine 92
Effects of photodynamic therapy on the absorption properties of disulphonated aluminum phthalocyanine in tumor-bearing mice 91
Time-gated fluorescence spectroscopy of porphyrin derivatives incorporated into cells 90
In vivo absorption spectrum of disulphonated aluminium phthalocyanine in a murine tumour model 90
Photodynamic therapy in experimental oncology with porphyrins and phthalocyanines 88
Time-resolved fluorescence spectroscopy of hematoporphyrin derivatives and disulfonated aluminum phthalocyanine incorporated in vivo in a murine ascitic tumor 88
Immunocytochemical staining of serous effusions 87
Time-gated fluorescence imaging for the diagnosis of tumors in different murine models 87
STUDIES OF THE EFFECT OF 2 PORPHYRINS ON THE LYMPHOHEMATOPOIETIC SYSTEM IN IRRADIATED MICE 85
Multispectral and lifetime imaging for the detection of skin tumors 85
Chemioterapici antitumorali: Alchilanti 84
Antitumor therapeutic efficacy of photoactivated phthalocyanines ZnS4Pc and AlS2Pc in tumor bearing mice 84
Time-gated fluorescence spectroscopy and imaging of porphyrins and phthalocyanines 82
Photodynamic therapy with photoactivated aluminum disulfonated phthalocyanine and cellular immune response 81
In-vivo incorporation of photosensitizing drugs in a murine ascitic tumor 81
Reversal of doxorubicin and cisplatin resistance in vivo in murine leukemias by the calcium antagonist RO 11-2933 78
Time-gated fluorescence spectroscopy of hematoporphyrin derivative incorporated in L1210 cells 76
Immunofarmacologia dei nuovi composti fotosensibilizzanti nella PDT dei tumori 75
Therapeutic efficacy and action spectrum of disulphonated aluminum phthalocyanine in vivo in a murine tumor model 69
Totale 13.145
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.329
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021976 0 0 0 0 154 47 46 40 153 59 364 113
2021/20221.068 98 41 35 88 102 85 65 61 46 107 131 209
2022/20231.315 174 148 120 156 149 308 17 79 95 12 39 18
2023/2024685 18 70 43 17 129 21 23 45 29 79 97 114
2024/20252.354 112 265 41 154 382 89 96 238 85 181 222 489
2025/20261.477 323 178 619 253 104 0 0 0 0 0 0 0
Totale 13.334